PR
Paul O Richins
Director

Paul O Richins insider trades: Utah Medical Products (UTMD) stock sales

Director, Utah Medical Products Last trade May 18, 2023 49 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2005
1
Company
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Paul reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 18, 2023UTMD↓ Sell$65K
Nov 18, 2022UTMD↓ Sell$41K
Nov 17, 2022UTMD↓ Sell$14K
Nov 11, 2022UTMD↓ Sell$4K
May 27, 2020UTMD↓ Sell$62K
May 31, 2016UTMD↓ Sell$26K
May 27, 2016UTMD↓ Sell$18K
Mar 3, 2008UTMD↓ Sell$18K
Dec 14, 2007UTMD↓ Sell$30K
Aug 22, 2006UTMD↓ Sell$30K
Dec 7, 2005UTMD↓ Sell$43K
Nov 16, 2005UTMD↓ Sell$12K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other UTMD insiders

Open-market trades in the last 12 months

About Paul O Richins's insider trades

Paul O Richins is a director at Utah Medical Products (UTMD). Since Nov 16, 2005, Paul has reported no open-market purchases and 12 sales worth $363K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include gifts (31 filings), option exercises (14 filings), shares withheld for taxes (7 filings), grants and awards (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every UTMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.